Eximo Medical: ANGO Stock Drops 16% Following $46 Million USD Eximo Acquisition

ANGO stock is down 16% today after MedDev company AngioDynamics Inc (NSADAQ:ANGO) agreed to acquire Eximo Medical for $46 million USD.The New York medical devices company has announced that it will acquire Israeli startup Eximo Medical Ltd, which develops a laser technology catheter device used for the treatment of occlusive peripheral arterial disease (PAD). The deal will see AngioDynamics pay $46 million USD upfront with an additional $20 million USD contingency depending on achieving certain milestones. Eximo's technology was clinically tested in Poland and is already being used on patients in the US; however, ANGO ...Read The Full Article On MicroSmallCap.comGet early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.